Bio/Pharma Business

CDMOs Announce Strategic Partnership for Fully Integrated Manufacturing Solutions

June 25, 2024

The pairing of Abzena and Argonaut Manufacturing Services is the result of several years’ worth of collaborative work between the two companies.

Demand Remains Strong for Mammalian Cell Culture Capacity (BIO 2024)

June 06, 2024

Lars Petersen, CEO, FUJIFILM Diosynth Biotechnologies discusses the company’s strategic goals and meeting market demand for mammalian cell culture capacity.

Lilly Raises Investment in Indiana Site to $9 Billion to Expand API Manufacturing

May 30, 2024

Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.

Johnson & Johnson to Acquire Global Rights to Numab Therapeutics’ Bispecific Antibody for Atopic Dermatitis in $1.25 Billion Deal

May 30, 2024

Johnson & Johnson will gain NM26, a bispecific antibody targeting atopic dermatitis, via the acquisition of a wholly owned subsidiary of Numab Therapeutics.

AGC Biologics Partners with BioConnection to Offer Biopharma Drug Substance and Drug Product Development and Manufacturing

May 25, 2024

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.

Biogen to Acquire HI-Bio in Deal Worth Potentially Up to $1.8 Billion

May 24, 2024

With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.

Merck KGaA Announces $600 Million Deal to Acquire Mirus Bio

May 24, 2024

With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.

AstraZeneca Plans $1.5 Billion ADCs Facility in Singapore

May 20, 2024

The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.

A Look at the Future of Bio/Pharma Partnerships at the US Pharma and Biotech Summit

May 17, 2024

Ken Keller, president and CEO, Daiichi Sankyo, discusses the foundation of partnership and takes a look at the future of biotech partnerships at the US Pharma and Biotech Summit.

IMA Life North America Breaks Ground on New Facility in Tonawanda, NY

May 17, 2024

The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.